Chiral Phosphoric Acid Catalyzed Enantioselective [4+3]-Cyclization Reaction of Indol-4-ylmethanols and Quinone Esters

Zhouli Chen; Lei Wang; Yiheng Qian; Xufeng Lin

doi:10.1055/a-1522-9361

Synlett, Table of Contents

Synlett 2021; 32(12): 1231-1235
DOI: 10.1055/a-1522-9361

letter

Chiral Phosphoric Acid Catalyzed Enantioselective [4+3]-Cyclization Reaction of Indol-4-ylmethanols and Quinone Esters

Zhouli Chen

,

Lei Wang

,

Yiheng Qian

,

Xufeng Lin ∗

Abstract

All articles of this category

Abstract

An asymmetric [4+3]-cyclization reaction of racemic indol-4-ylmethanols and quinone esters catalyzed by chiral phosphoric acids has been developed. This method provides efficient access to biologically important [1]benzoxepino[5,4,3-cd]indoles featuring both axial and central chirality in good yields and up to 98% ee, as essentially single diastereomers, under mild reaction conditions.

Key words

chiral phosphoric acids - [4+3]-cycloaddition - asymmetric catalysis - indoles - quinones - benzoxepinoindoles

Full Text

References

References and Notes

1a Renfroe B, Harrington C, Proctor GR. The Chemistry of Heterocyclic Compounds, Vol. 43, Azepines . Wiley Interscience; New York: 1984
1b Ogawa H, Yamashita H, Kondo K, Yamamura Y, Miyamoto H, Kan K, Kitano K, Tanaka M, Nakaya K, Nakamura S, Mori T, Tominaga M, Yabuuchi Y. J. Med. Chem. 1996; 39: 3547
1c Comprehensive Heterocyclic Chemistry III . Katritzky AR, Ramsden CA, Scriven EF. V, Taylor RJ. K. Elsevier Science Direct; Amsterdam: 2008
1d Ryan JH, Hyland C, Meyer AG, Smith JA, Yin JX. Prog. Heterocycl. Chem. 2012; 24: 493

2a Ylijoki KE. O, Stryker JM. Chem. Rev. 2013; 113: 2244
2b Pellissier H. Adv. Synth. Catal. 2018; 360: 1551
2c Wender PA, Pedersen TM, Scanio MJ. C. J. Am. Chem. Soc. 2002; 124: 15154
2d Zhou M.-B, Song R.-J, Wang C.-Y, Li J.-H. Angew. Chem. Int. Ed. 2013; 52: 10805
2e Hu C, Song R.-J, Hu M, Yang Y, Li J.-H, Luo S. Angew. Chem. Int. Ed. 2016; 55: 10423
2f Cui L, Ye L, Zhang L. Chem. Commun. 2010; 46: 3351
2g Li T, Xu F, Li X, Wang C, Wan B. Angew. Chem. Int. Ed. 2016; 55: 2861

3a Anslyn EV, Dougherty DA. Modern Physical Organic Chemistry . University Science; Sausalito: 2006
3b Galli C, Mandolini L. Eur. J. Org. Chem. 2000; 3117

4a Selvaraj K, Chauhan S, Sandeep K, Swamy KC. K. Chem. Asian J. 2020; 15: 2380
4b Shintani R, Murakami M, Hayashi T. J. Am. Chem. Soc. 2007; 129: 12356
4c Hu J.-L, Wang L, Xu H, Xie Z, Tang Y. Org. Lett. 2015; 17: 2680
4d Wei L, Yao L, Wang Z.-F, Li H, Tao H.-Y, Wang C.-J. Adv. Synth. Catal. 2016; 358: 3748
4e Wang M, Huang Z, Xu J, Chi YR. J. Am. Chem. Soc. 2014; 136: 1214
4f Yuan C, Zhou L, Xia M, Sun Z, Wang D, Guo H. Org. Lett. 2016; 18: 5644
4g Lv H, Jia W.-Q, Sun L.-H, Ye S. Angew. Chem. Int. Ed. 2013; 52: 8607
4h Izquierdo J, Orue A, Scheidt KA. J. Am. Chem. Soc. 2013; 135: 10634
4i Guo C, Sahoo B, Daniliuc CG, Glorius F. J. Am. Chem. Soc. 2014; 136: 17402
4j Zhu S.-Y, Zhang Y, Wang W, Hui X.-P. Org. Lett. 2017; 19: 5380
4k Trost BM, Zuo Z. Angew. Chem. Int. Ed. 2020; 59: 1243
4l Villar L, Uria U, Martínez JI, Prieto L, Reyes E, Carrillo L, Vicario JL. Angew. Chem. Int. Ed. 2017; 56: 10535
4m Lam H, Qureshi Z, Wegmann M, Lautens M. Angew. Chem. Int. Ed. 2018; 57: 16185
4n Xu C, Qiao J, Dong S, Zhou Y, Liu X, Feng X. Chem. Sci. 2021; 12: 5458
4o Loui HJ, Suneja A, Schneider C. Org. Lett. 2021; 23: 2578
4p Suneja A, Loui HJ, Schneider C. Angew. Chem. Int. Ed. 2020; 59: 5536
4q Gao Y, Song X, Yan R.-J, Du W, Chen Y.-C. Org. Biomol. Chem. 2021; 19: 151
4r Gelis C, Levitre G, Merad J, Retailleau P, Neuville L, Masson G. Angew. Chem. Int. Ed. 2018; 57: 12121
4s Xu G, Chen L, Sun J. Org. Lett. 2018; 20: 3408

5a Liu Y.-Z, Wang Z, Huang Z, Zheng X, Yang W.-L, Deng W.-P. Angew. Chem. Int. Ed. 2020; 59: 1238
5b Sun M, Ma C, Zhou S.-J, Lou S.-F, Xiao J, Jiao Y, Shi F. Angew. Chem. Int. Ed. 2019; 58: 8703
5c Tan Q, Yu H, Luo Y, Chang F, Liu X, Zhou Y, Feng X. Chem. Commun. 2021; 57: 3018
5d Kumari P, Liu W, Wang C.-J, Dai J, Wang M.-X, Yang Q.-Q, Deng Y.-H, Shao Z. Chin. J. Chem. 2020; 38: 151

6a Xu F, Huang D, Han C, Shen W, Lin X, Wang Y. J. Org. Chem. 2010; 75: 8677
6b Xu F, Huang D, Lin X, Wang Y. Org. Biomol. Chem. 2012; 10: 4467
6c Huang D, Xu F, Lin X, Wang Y. Chem. Eur. J. 2012; 18: 3148
6d Li X, Zhao Y, Qu H, Mao Z, Lin X. Chem. Commun. 2013; 49: 1401
6e Huang D, Li X, Xu F, Li L, Lin X. ACS Catal. 2013; 3: 2244
6f Shen X, Wang Y, Wu T, Mao Z, Lin X. Chem. Eur. J. 2015; 21: 9039
6g Lou H, Wang Y, Jin E, Lin X. J. Org. Chem. 2016; 81: 2019
6h Xie E, Rahman A, Lin X. Org. Chem. Front. 2017; 4: 1407
6i Rahman A, Xie E, Lin X. Org. Biomol. Chem. 2018; 16: 1367
6j Wang L, Zhong J, Lin X. Angew. Chem. Int. Ed. 2019; 58: 15824
6k Luo J, Zhang T, Wang L, Liao G, Yao Q.-J, Wu Y.-J, Zhan B.-B, Lan Y, Lin X.-F, Shi B.-F. Angew. Chem. Int. Ed. 2019; 58: 6708
6l Zhan B.-B, Wang L, Luo J, Lin X.-F, Shi B.-F. Angew. Chem. Int. Ed. 2020; 59: 3568
6m Zhan B.-B, Jia Z.-S, Luo J, Jin L, Lin X.-F, Shi B.-F. Org. Lett. 2020; 22: 9693
6n Wang L, Zhong J, Lin X. Synlett 2021; 32: 417
6o Mao Z, Mo F, Lin X. Synlett 2016; 27: 546

For recent reviews, see:

6p Rahman A, Lin X. Org. Biomol. Chem. 2018; 16: 4753
6q Lin X, Wang L, Han Z, Chen Z. Chin. J. Chem. 2021; 39: 802

7a Akiyama T, Itoh J, Yokota K, Fuchibe K. Angew. Chem. Int. Ed. 2004; 43: 1566
7b Uraguchi D, Terada M. J. Am. Chem. Soc. 2004; 126: 5356

For reviews, see:

7c Akiyama T, Itoh J, Fuchibe K. Adv. Synth. Catal. 2006; 348: 999
7d Akiyama T. Chem. Rev. 2007; 107: 5744
7e Terada M. Chem. Commun. 2008; 4097
7f Adair G, Mukherjee S, List B. Aldrichimica Acta 2008; 41: 31
7g You S.-L, Cai Q, Zeng M. Chem. Soc. Rev. 2009; 38: 2190
7h Terada M. Synthesis 2010; 1929
7i Rueping M, Kuenkel A, Atodiresei I. Chem. Soc. Rev. 2011; 40: 4539
7j Parmar D, Sugiono E, Raja S, Rueping M. Chem. Rev. 2014; 114: 9047

8 2,6-Dihydro[1]benzoxepino[5,4,3-cd]indoles 3a–o: General Procedure To a mixture of the appropriate indol-4-ylmethanol 1 (0.05 mmol) and catalyst (S)-4a (0.0025 mmol, 5 mol%) in DCE (0.5 mL) was added the quinone ester 2 (0.06 mmol, 1.2 equiv), and the mixture was stirred at RT for 2 h. The resulting mixture was then purified by flash column chromatography [silica gel, EtOAc–PE (1:4)]. Methyl (6R)-10-Hydroxy-6-phenyl-2,6-dihydro[1]benzoxepino[5,4,3-cd]indole-11-carboxylate (3a) White solid; yield: 16.0 mg (86%; 98% ee); mp 260–261 °C; [α]_D ²⁰ –34.100 (c 1.00, CH₂Cl₂). HPLC [Daicel Chiralcel OD-H (250 × 4.6 mm), hexane/i-PrOH (70:30, 1.0 mL/min), λ = 254 nm]: t _R(major) = 8.680 min; t _R(minor) = 12.459 min. IR (film): 3391, 3297, 2952, 2925, 2853, 1705, 1536, 1443, 1319, 1212, 1125, 994, 864, 752 cm^–1. ¹H NMR (400 MHz, DMSO-d ₆): δ = 11.57 (d, J = 2.8 Hz, 1 H), 9.63 (s, 1 H), 7.64–7.13 (m, 7 H), 7.12–5.78 (m, 5 H), 3.80 (s, 3 H). ¹³C NMR (101 MHz, DMSO-d ₆): δ = 169.94, 151.13, 140.19, 136.05, 135.94, 128.69, 128.43, 126.57, 126.51, 124.84, 123.29, 121.63, 121.32, 120.16, 117.39, 116.14, 113.32, 111.86, 111.36, 86.55, 52.73. HRMS (ESI⁺): m/z [M + H]⁺ calcd for C₂₃H₁₈NO₄: 372.1230; found: 372.1231.
9 Methyl (6R)-10-(Benzoyloxy)-6-phenyl-2,6-dihydro[1]benzoxepino[5,4,3-cd]indole-11-carboxylate (7) BzCl (0.1 mmol) was added to a mixture of 3a (0.1 mmol) and Et₃N (0.2 mmol) in CH₂Cl₂ (1 mL) cooled in an ice bath. The temperature was then increased to r.t and the mixture was stirred for 3 h then washed with H₂O. The organic phase was purified by flash column chromatography [silica gel, EtOAc–PE (1:4)] to give a white solid; yield: 41.3 mg (87%, 96% ee); mp 145–147 °C; [α]_D ²⁰ –25.8 (c 1.00, CH₂Cl₂). HPLC [Daicel Chiralpak AD-H column (250 × 4.6 mm), hexane–i-PrOH (70:30, 1.0 mL/min), λ = 254 nm]: t _R(major) = 14.899 min; t _R(minor) = 11.810 min. IR (film): = 3396, 3063, 3033, 2950, 2925, 1735, 1599, 1537, 1442, 1272, 1215, 1083, 1067, 1021, 731, 707, 669 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 8.71–8.63 (m, 1 H), 8.17 (dd, J = 8.0, 1.4 Hz, 2 H), 7.68–7.61 (m, 1 H), 7.51 (t, J = 7.7 Hz, 2 H), 7.47–7.34 (m, 6 H), 7.27 (d, J = 8.2 Hz, 1 H), 7.16 (s, 1 H), 7.01 (t, J = 7.8 Hz, 2 H), 6.22 (d, J = 85.3 Hz, 2 H), 3.73 (s, 3 H). ¹³C NMR (101 MHz, CDCl₃): δ = 168.69, 164.89, 144.21, 139.20, 135.39, 133.78, 130.16, 128.98, 128.65, 128.42, 128.41, 128.31, 128.14, 127.09, 125.18, 124.51, 122.79, 122.08, 120.15, 118.16, 111.90, 111.11, 86.77, 77.20, 52.69. HRMS (ESI⁺): m/z [M + Na]⁺ calcd for C₃₀H₂₁NNaO₅: 498.1312; found: 498.1313. CCDC 2081158 contains the supplementary crystallographic data for compound 7. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
10 Methyl (6R)-10-Hydroxy-6-phenyl-2,6-dihydro[1]benzoxepino[5,4,3-cd]indole-11-carboxylate (3a): 1 mmol Scale Reaction To a mixture of indol-4-ylmethanol 1a (1 mmol) and catalyst (S)-4a (0.05 mmol, 5 mol%) in DCE (5 mL) was added quinone ester 2a (1.2 mmol, 1.2 equiv), and the mixture was stirred at RT for 2 h. The mixture was then purified by flash column chromatography [silica gel, EtOAc–PE (1:4)] to give a white solid; yield: 289.5 mg [78%; 93% ee (99% ee after crystallization)].
11 Methyl 6-Phenyl-10-(tosylamino)-2,6-dihydro[1]benzoxepino[5,4,3-cd]indole-11-carboxylate (8) To a mixture of indol-4-ylmethanol 1 (0.05 mmol) and catalyst (R)-4h (0.005 mmol, 10 mol%) in DCE (0.5 mL) was added iminoquinone 8 (0.06 mmol, 1.2 equiv), and the mixture was stirred at RT for 6 h. The resulting mixture was then purified by flash column chromatography [silica gel, EtOAc–PE (1:4)] to give a white solid; yield: 21.4 mg (92%; 60% ee); mp 164–167 °C; [α]_D ²⁰ +14.023 (c 0.55, CH₂Cl₂). HPLC [Daicel Chiralpak IA column (250 × 4.6 mm), hexane/i-PrOH (70:30, 1.0 mL/min), λ = 254 nm]: t _R(major) = 15.998 min, t _R(minor) = 12.919 min. IR (film): 3400, 3268, 2955, 2925, 2854, 1609, 1545, 1479, 1385, 1305, 1159, 1091, 918, 813, 752, 665, 541 cm^–1. ¹H NMR (400 MHz, DMSO-d ₆): δ = 11.62 (d, J = 2.7 Hz, 1 H), 9.96 (s, 1 H), 7.68 (d, J = 2.7 Hz, 1 H), 7.60 (d, J = 7.9 Hz, 2 H), 7.43 (d, J = 2.6 Hz, 1 H), 7.40 (d, J = 8.1 Hz, 1 H), 7.31 (m, 5 H), 7.21 (m, 2 H), 7.01 (dd, J = 7.7, 7.7 Hz, 1 H), 6.74 (d, J = 8.6 Hz, 1 H), 6.63 (dd, J = 8.6, 2.6 Hz, 1 H), 6.36 (d, J = 7.3 Hz, 1 H), 6.22 (s, 1 H), 2.33 (s, 3 H). ¹³C NMR (101 MHz, DMSO-d ₆): δ = 152.65, 143.51, 139.92, 137.19, 136.72, 135.72, 133.91, 130.06, 129.66, 128.94, 128.54, 128.33, 127.25, 124.57, 124.33, 122.64, 121.58, 119.09, 118.50, 117.41, 113.39, 111.90, 85.42, 21.44. HRMS (ESI⁺): m/z [M + Na]⁺calcd for C₂₈H₂₂N₂NaO₃S: 489.1243; found: 489.1244.
12 Methyl 10-Hydroxy-2-methyl-6-phenyl-2,6-dihydro[1]benzoxepino[5,4,3-cd]indole-11-carboxylate (11) To a mixture of the indol-4-ylmethanol 10 (0.05 mmol) and catalyst (S)-4a (0.0025 mmol, 5 mol%) in DCE (0.5 mL) was added quinone ester 2a (0.06 mmol, 1.2 equiv) and the mixture was stirred at RT for 2 h. The mixture was then purified by flash column chromatography [silica gel, EtOAc–PE (1:4)] to give a yellow solid; yield: 16.2 mg (84%; 24% ee); mp 247–249 °C; [α]_D ²⁰ –6.830 (c 0.58, CH₂Cl₂). HPLC [Daicel Chiralcel OD-H column (250 × 4.6 mm), hexane–i-PrOH (70:30, 1.0 mL/min), λ = 254 nm]: t _R(major) = 12.721 min, t _R(minor) = 9.747 min. IR (film): 3439, 3377, 2925, 1728, 1537, 1466, 1322, 1266, 1207, 1122, 1066, 995, 750 cm^–1. ¹H NMR (400 MHz, DMSO-d ₆): δ = 9.67 (s, 1 H), 7.67–7.18 (m, 7 H), 7.11–5.87 (m, 5 H), 3.89 (s, 3 H), 3.85 (s, 3 H). ¹³C NMR (101 MHz, DMSO): δ = 169.79, 151.15, 140.11, 139.80, 136.69, 128.97, 128.70, 128.46, 127.26, 126.21, 126.07, 125.14, 124.79, 121.73, 120.10, 117.60, 113.41, 110.59, 110.18, 86.32, 52.87, 33.43. HRMS (ESI⁺): m/z [M + H]⁺ calcd for C₂₄H₂₀NO₄: 386.1387; found: 386.1386.

Supplementary Material

Supporting Information